Giovanny covers investment trends for CNBC Pro, CNBC's premium digital-content platform, with a focus on equities, global markets, currencies and commodities.
Prior to this role, he spent five years as the lead quantitative analyst for CNBC Television, partnering with reporters and show units to provide research and analytics related to the stock market.
His expertise spans across multiple industries and asset classes with an emphasis on telling the story through the numbers.
Follow Giovanny Moreano on Twitter @GiovannyMoreano.
The bear case for stocks will soon be losing backers as a pickup in earnings and optimistic economic projections could take stocks higher.
Three U.S. senators are slamming the drug firm for jacking up the cost of its anaphylaxis treatment more than fivefold.
CNBC's Rick Santelli and Lindsey Group's Peter Boockvar discuss why government programs continue to fail.
Traders are loving Pfizer more, according to data showing an increase in bullish mentions of the stock on Twitter.
The president of Financial Insyghts discusses how social mood can help investors predict financial market cycles.
Top Wall Street strategist Tony Dwyer warned investors to not throw in the towel on this bull market just yet.
Richard Madigan, who's responsible for the strategic allocation of more than $1 trillion at JPMorgan Private Bank, sees overvalued asset classes.